Instruction for use: Beconase

ATX Code R01AD01 Beclometasone

Active substance: Beclometasone

Pharmacological group

Glucocorticosteroids

Nosological classification (ICD-10)

J31 Chronic rhinitis, nasopharyngitis and pharyngitis

Allergic rhinosinusopathy, Inflammation of the nasal mucosa, Infectious-inflammatory diseases of upper respiratory tract, Catarrh nasopharyngeal area, Year-round rhinitis, Özen, Sore throat or nose hyperplastic, Rhinitis, Faringoezofagit, Chronic bacterial rhinitis

Composition and form of release

1 dose of spray for intranasal use contains beclometasone 50 μg; In a can of 200 doses.

pharmachologic effect

Pharmacological action - antiallergic.

Has glucocorticoid activity.

Clinical Pharmacology

Helps reduce the number of mast cells in the mucous membrane of the bronchi and nose, reduce the edema of the epithelium and the secretion of mucus by the bronchial glands. It causes relaxation of the smooth muscles of the bronchi, reduces their hyperreactivity, improves the parameters of external respiration. Compared with the systemic effect of inhalation, significantly reduces the risk of side effects. Does not have mineralocorticoid activity. Restores patient's reaction to bronchodilators, allowing to reduce the frequency of their use. With hormone-dependent bronchial asthma it is possible to reduce the dose of oral glucocorticoid agents.

Indications

Allergic rhinitis - year-round and seasonal (prevention and treatment).

Contraindications

Hypersensitivity.

pregnancy and lactation

It is permissible, but it is necessary to estimate the prospective benefit for the mother and the possible risk for the child.

Side effects

Attacks of sneezing (immediately after inhalation), perforation of the nasal septum (single cases).

Dosing and Administration

Intranasally. Adults and children over 6 years of age have 2 injections in each nostril 2 times a day (400 mcg / day) or 1 in each nostril 3-4 times a day, but not more than 8 per day. To obtain the full therapeutic effect, regular use is necessary, since The effect occurs only after several inhalations.

Overdose

With inhalation of high doses, oppression of the hypothalamic-pituitary-adrenal function is possible. It should continue to use the drug in the recommended dosages, and the hypothalamic-pituitary-adrenal function will return to normal within 1-2 days.

Precautionary measures

With the infection of the nasal passages and paranasal sinuses, appropriate treatment is indicated. It is advisable to transfer patients with caution from steroids of general action to Baconase, if they have a disrupted adrenal function.

storage Conditions

In the dark place at a temperature below 30 ° C. (Not in the refrigerator).

Keep out of the reach of children.

Shelf life

2 years.

Do not use after the expiry date printed on the package.